Search

Your search keyword '"Ramani, F"' showing total 66 results

Search Constraints

Start Over You searched for: Author "Ramani, F" Remove constraint Author: "Ramani, F"
66 results on '"Ramani, F"'

Search Results

1. Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: Insights from the START study

2. Congenital heart disease in the ESC EORP Registry of Pregnancy and Cardiac disease (ROPAC)

3. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

4. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

5. Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: insights from the START Study

6. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

7. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

8. COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: Insights from the STARTregistry

9. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry

10. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry

11. COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: Insights from the STARTregistry

13. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

14. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

16. Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study

17. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

18. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

19. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

20. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry

21. Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

23. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

24. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

25. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

27. Poor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathy

28. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management:baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry

29. Congenital heart disease in the ESC EORP Registry of Pregnancy and Cardiac disease (ROPAC)

30. Cohort profile. the ESC-EORP chronic ischemic cardiovascular disease long-term (CICD LT) registry

31. Poster session 3

32. Thromboembolic events in peripartum cardiomyopathy: results from the ESC EORP PPCM registry

33. Pregnancy Outcomes in Women After Arterial Switch Operation for Transposition of the Great Arteries: Results From ROPAC (Registry of Pregnancy and Cardiac Disease) of the European Society of Cardiology EURObservational Research Programme

34. Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC)

35. Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy

36. Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction

37. Pregnancy outcome in thoracic aortic disease data from the Registry Of Pregnancy And Cardiac disease

38. Sex Differences in the Long-term Prognosis of Dilated Cardiomyopathy

39. Risk of sudden cardiac death in New York Heart Association class I patients with dilated cardiomyopathy: A competing risk analysis

40. Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History

41. Prognostic impact of short-term changes of E/E' ratio and left atrial size in dilated cardiomyopathy

42. Longitudinal Arrhythmic Risk Assessment Based on Ejection Fraction in Patients with Recent-Onset Nonischemic Dilated Cardiomyopathy.

43. Transient versus persistent improved ejection fraction in non-ischaemic dilated cardiomyopathy.

44. Prevalence and Evolution of Right Ventricular Dysfunction Among Different Genetic Backgrounds in Dilated Cardiomyopathy.

45. [Diagnostic work-up and clinical management of cardiomyopathies: the operative protocol from the Cardiothoracovascular Department of Trieste, Italy].

46. Sex-Specific Prognostic Implications in Dilated Cardiomyopathy After Left Ventricular Reverse Remodeling.

47. Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy.

48. Risk of sudden cardiac death in New York Heart Association class I patients with dilated cardiomyopathy: A competing risk analysis.

49. Sex Differences in the Long-term Prognosis of Dilated Cardiomyopathy.

50. Prognostic impact of short-term changes of E/E' ratio and left atrial size in dilated cardiomyopathy.

Catalog

Books, media, physical & digital resources